An American healthcare company using artificial intelligence to diagnose depression.
Depression is still mostly diagnosed by conversation and questionnaire. Ascertain is building an objective, AI-driven diagnostic, aimed at helping doctors confirm the condition and choose the treatment most likely to work.
Goldhorn works closely with Ascertain's leadership as a strategic partner.